Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
Crossref DOI link: https://doi.org/10.4103/1110-7782.182956
Published Online: 2016-05-25
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elsaadany, Hossam M.
Almaghraby, Mohammed F.
Edrees, Awatif A.
Elsherbiny, Yasser M.
Kumar, Roobina K.
Text and Data Mining valid from 2016-03-01
Article History
Received: 7 December 2015
Accepted: 16 February 2016
First Online: 25 May 2016